FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry and deals with medication, obtained by interaction of selenium-containing compound with alpha, alpha-dichlorcarboxylic acid, stabilised by nitric acid in amount not more than 5 wt %. As selenium-containing compound in interaction used is solution of selenious acid in amount not more than 20.0 wt %. Medication can additionally contain dimethylsulfoxide in amount 5-20%. Method of obtaining medication is realised by interaction of selenium-containing compound with alpha, alpha-dichlorcarboxylic acid, stabilised by nitric acid in amount not more than 5 wt %, and as selenium-containing compound in interaction used is solution of selenious acid in amount 0.5-20.0 wt % and interaction is realised at temperature not higher than 70°C. In application of medication for treatment of benign, viral, pre-malignant and malignant non-metastatic skin lesions, dysplastic lesions of visible mucous membranes and other skin lesions, it is applied on lesion nidus on the 1, 2-3, 7-9 and 22-24 days of treatment.
EFFECT: medication possesses higher stability and efficiency.
8 cl, 4 ex, 3 tbl
